Also trades as: FUM.L (LSE) · $vol 0M
FAMDF OTC
Futura Medical plc
1W: +33.3%
1M: +12.0%
3M: -60.0%
YTD: -72.0%
1Y: -94.4%
3Y: -99.6%
5Y: -99.5%
$0.00
-0.00 (-30.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.0M
52W Range0.0014-0.053
Volume1,540,000
Avg Volume34,834
Beta0.00
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOAlex Duggan
Employees14
SectorHealthcare
IndustryBiotechnology
IPO Date2012-05-15
Websitefuturamedical.com
Surrey Technology Centre
Guildford, SU GU2 7YG
GB
Guildford, SU GU2 7YG
GB
44 14 8368 5670
About Futura Medical plc
Futura Medical plc is a pharmaceutical company that formulates and brings to market healthcare solutions and medicines for the consumer sector, primarily concentrating on sexual well-being and managing discomfort. Their flagship product, MED3000, is a topical gel specifically developed to address erectile dysfunction. The company's pipeline also encompasses a range of pain relief treatments, featuring TPR100, a topical diclofenac gel; CBD100, a topical cannabidiol preparation; and TIB200, a topical ibuprofen gel. Established in 2001, Futura Medical plc operates from its headquarters located in Guildford, United Kingdom.
Latest News
Futura Medical (LON:FUM) Shares Down 4.4% – Here’s Why
Futura Medical (LON:FUM) Shares Cross Below 200-Day Moving Average – Here’s Why
Nasdaq set to lead decline as Alphabet spending plans spook investors
Nasdaq drags major indexes lower as Alphabet spending plans spook investors
Futura secures US patent protection for Eroxon and women's sexual health product
Recent Insider Trades
No insider trades found